This panel will discuss developments in pain management and treatment, including initiatives to adopt and implement standardized clinical guidelines for opioid prescriptions, as well as updates on recent State of Delaware regulatory changes about opioid prescriptions in hospital setting and for chronic pain patients. Potential legal impact of these developments – including prescriber liability issues and litigation, related law enforcement initiatives, and others. Update on recent developments and current topics in opioid policy, including an overview of legislation recently enacted by the Delaware General Assembly and proposals currently being considered by Congress to address the opioid epidemic and eliminate some of the existing statutory and regulatory barriers to sharing substance abuse treatment data.
Andrew B. Wilson is a legislative specialist in Morris James' Health Care Industry and Government Relations Groups. Andrew works on a range of healthcare issues throughout the practice of medicine, assisting clinicians, practices, and other entities through licensing questions, regulatory compliance, and generally how to grow their practices.